cvd

* Treatment should be embedded in structured monitoring of hematocrit, blood pressure, renal and hepatic function, and cardiac rhythm, and coupled with active management of coexisting obesity, sleep apnea, diabetes, hypertension, and dyslipidemia, each of which independently influences AF risk...

* Despite these limitations, this study provides a large-scale, head-to-head comparison of men receiving testosterone therapy with vs without evidence of hypogonadism, with up to 10 years of follow-up, race/ethnicity stratification, rigorous propensity-score matching, and complementary modelling...

* Dr. Patel emphasizes that real-world prescribing often differs from controlled trial conditions, particularly with injectable formulations that may result in higher testosterone peaks and greater hematologic effects. * Dr. Patel stresses the need for careful cardiovascular screening, patient...

* TRT does not increase MACE risk in men with confirmed organic hypogonadism when titrated to physiological levels. Non-MACE signals warrant vigilance rather than contraindication. Metabolic optimisation should precede TRT in functional hypogonadism. Individualised monitoring and careful patient...

Must listen here! Most men think erectile dysfunction is a bedroom problem and low testosterone is just a fact of getting older. This roundtable makes the case that both are early warning lights for your heart, your metabolism, and your long-term health and that ignoring them can cost...

* Clear Heart was built to solve that problem, offering direct-to-consumer self-pay access alongside physician referrals, with no 6-week hospital wait and results within 24 hours What does a cardiac CT scan actually show? In this video, Dr. Matthew Budoff - Professor of Medicine at the...

Incretin-Based Therapies Goals for Today

Most men think erectile dysfunction is a bedroom problem. It's actually one of the earliest warning signs of cardiovascular disease, capable of showing up three to five years before a heart attack.In this episode, Dr. Gabrielle Lyon sits down with Dr. Amy Pearlman, a urologist trained in...

https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423

In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: Overview • PV and ET increase the risk of both arterial and venous thrombotic...

How do you turn your patients' calcium scores into clear, personalized prevention plans?

Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed hazard ratio and 1-year outcome of major adverse cardiac events (MACE) to depending on...

Abstract INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED) affects over 70% of men with end-stage renal disease (ESRD), yet the cardiovascular safety of phosphodiesterase type 5 inhibitors (PDE5i) in this population remains poorly understood. Concerns persist due to altered...

Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed risk ratios and outcome of major adverse cardiovascular to depending on different period...

https://www.cbc.ca/listen/cbc-podcasts/410-the-dose/episode/16210375-what-can-erectile-dysfunction-say-about-mens-health Erectile dysfunction is commonly thought of as a sexual health issue, but experts say the condition can reveal a lot about men's health. Dr. Dean Elterman, a urologist at the...

https://www.nejm.org/doi/abs/10.1056/NEJMra2202438

Dr. Khera of course! * if you prescribe testosterone there are five controversies you have to know about! Mohit Khera, MD, MBA, MPH Professor of Urology F. Brantley Scott Chair in Urology Director, Laboratory for Andrology Research Faculty Group Practice Medical Director Baylor College...

Sexual medicine is underfunded, misunderstood, and often dismissed. But it's also one of the most collaborative fields in healthcare. Dr. Tami Rowen and I recap this year's ISSWSH conference and what it revealed about where the field is heading. Dr. Tami Rowen is an associate professor of OBGYN...

As we close out Black History Month, we shine a necessary spotlight on a living legend whose name deserves to be spoken with the same weight as the breakthroughs he helped create. Dr. Arthur Burnett is a world-renowned urologist whose groundbreaking research around nitric oxide pathways helped...

* Substantial evidence suggests that sleep disorders may impair testosterone levels, partially improved after specific treatments (for instance: positive airway pressure for OSA). On the other hand, appropriate indications for testosterone replacement therapy (TRT) can alleviate hypogonadism...

How often should men on TRT check their hematocrit? The standard monitoring schedule includes a baseline CBC before starting TRT, a recheck at 3 to 6 weeks, another at 3 months, and then at 6 and 12 months once stable. Any dose or formulation change resets the monitoring clock, requiring a...

Dr. Peter Wilson I am going to give you some pearls from recent talks. 1:28-2:19 * Shehzad Basaria from Harvard who's on the TRAVERSE Trial. He said one of the biggest mistakes were making is assuming free testosterone is correct. Thats important and I think we in endocrinology and urology...

Take home message

Heart disease risk isn’t just about cholesterol. In this episode of A Whole New Level, Dr. Matthew Budoff explains why coronary artery calcium (CAC) scoring may be the most important test most people aren’t getting—and why imaging your arteries directly can reveal risk that blood tests alone can...

Diagnostic Assessment Strategy: Cardiovascular Risk & Systemic Health in Hypogonadal Patients 1. Strategic Framework for Cardiovascular Risk in the Hypogonadal Male In the contemporary clinical landscape, the management of the hypogonadal male demands a multi-modal assessment strategy that...

"Cardiometabolic Health: Do Sex Steroids Matter?" which looks at the role sex steroids play in cardiovascular health across the lifespan. Susan R. Davis My team who have contributed to the work presented Conclusions

* Chronic exposure to supraphysiologic doses of AAS induces a variety of pathophysiological changes in the cardiovascular system. The mechanisms are multifactorial, involving direct androgen receptor-mediated effects on cardiac and vascular tissues as well as indirect metabolic and hemodynamic...

* However, Mills argues that safety alone is not the benchmark for quality care. Men presenting with symptoms of low testosterone often have multiple comorbidities—poor sleep, sedentary lifestyle, suboptimal diet, or uncontrolled CV risk factors—that should be addressed alongside or even before...

* Finally, Bernie noted unresolved controversies in the field, including the optimal duration of fertility-preserving therapies, long-term outcomes of hybrid regimens combining testosterone with hCG, and best practices for sperm recovery after prolonged testosterone exposure. She emphasized the...

Listen closely here! 11:55-12:13 * you only need testosterone levels up for about 4-6 hrs in the day to produce an effect which works through the androgen receptor, the androgen receptor is present in every cell in the body so its not just a sex hormone it is a health hormone Another...